Walker BD - Search Results

1

Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infection.

Tremblay CL, Hicks JL, Sutton L, Giguel F, Flynn T, Johnston M, Sax PE, Walker BD, Hirsch MS, Rosenberg ES, D'Aquila RT. Tremblay CL, et al. Among authors: walker bd. AIDS. 2003 May 2;17(7):1086-9. doi: 10.1097/00002030-200305020-00021. AIDS. 2003. PMID: 12700462

2

Cytotoxic T lymphocytes against HIV.

Walker BD, Plata F. Walker BD, et al. AIDS. 1990 Mar;4(3):177-84. doi: 10.1097/00002030-199003000-00001. AIDS. 1990. PMID: 1693514 Review.

3

HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals.

Walker BD, Flexner C, Paradis TJ, Fuller TC, Hirsch MS, Schooley RT, Moss B. Walker BD, et al. Science. 1988 Apr 1;240(4848):64-6. doi: 10.1126/science.2451288. Science. 1988. PMID: 2451288

4

Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine.

Johnson VA, Walker BD, Barlow MA, Paradis TJ, Chou TC, Hirsch MS. Johnson VA, et al. Among authors: walker bd. Antimicrob Agents Chemother. 1989 Jan;33(1):53-7. doi: 10.1128/AAC.33.1.53. Antimicrob Agents Chemother. 1989. PMID: 2653214 Free PMC article.

5

Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine.

Johnson VA, Barlow MA, Chou TC, Fisher RA, Walker BD, Hirsch MS, Schooley RT. Johnson VA, et al. Among authors: walker bd. J Infect Dis. 1989 May;159(5):837-44. doi: 10.1093/infdis/159.5.837. J Infect Dis. 1989. PMID: 2785146

6

HIV infection is blocked in vitro by recombinant soluble CD4.

Fisher RA, Bertonis JM, Meier W, Johnson VA, Costopoulos DS, Liu T, Tizard R, Walker BD, Hirsch MS, Schooley RT, et al. Fisher RA, et al. Among authors: walker bd. Nature. 1988 Jan 7;331(6151):76-8. doi: 10.1038/331076a0. Nature. 1988. PMID: 2829022

7

HIV-specific cytotoxic T lymphocytes in seropositive individuals.

Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT. Walker BD, et al. Nature. 1987 Jul 23-29;328(6128):345-8. doi: 10.1038/328345a0. Nature. 1987. PMID: 3496541

8

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.

Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo HS, D'Aquila RT, Kurnick JT, Walker BD. Kalams SA, et al. Among authors: walker bd. J Exp Med. 1994 Apr 1;179(4):1261-71. doi: 10.1084/jem.179.4.1261. J Exp Med. 1994. PMID: 8145043 Free PMC article.

9

The rationale for immunotherapy in HIV-1 infection.

Walker BD. Walker BD. J Acquir Immune Defic Syndr (1988). 1994;7 Suppl 1:S6-13. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8182510 Review.

10

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.

Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD. Rosenberg ES, et al. Among authors: walker bd. Science. 1997 Nov 21;278(5342):1447-50. doi: 10.1126/science.278.5342.1447. Science. 1997. PMID: 9367954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

673 results

Search Page

Filters